OTC Markets OTCPK - Delayed Quote
USD
Adaptimmune Therapeutics plc (ADAPY)
0.0190
-0.0010
(-5.00%)
At close: November 5 at 4:00:00 PM EST
Loading chart for ADAPY
- Previous Close
0.0200 - Open
0.0176 - Bid 0.0180 x 18610200
- Ask 0.0189 x 66075600
- Day's Range
0.0171 - 0.0189 - 52 Week Range
0.0010 - 0.0700 - Volume
154,890 - Avg. Volume
191,712 - Market Cap (intraday)
5.036M - Beta (5Y Monthly) 0.83
- PE Ratio (TTM)
-- - EPS (TTM)
-0.6700 - Earnings Date (est.) --
- Forward Dividend & Yield -- (0.00%)
- Ex-Dividend Date --
- 1y Target Est
--
Recent News
View MorePerformance Overview
Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
ADAPY
32.14%
MSCI WORLD (^990100-USD-STRD)
6.62%
1-Year Return
ADAPY
47.22%
MSCI WORLD (^990100-USD-STRD)
9.25%
3-Year Return
ADAPY
96.61%
MSCI WORLD (^990100-USD-STRD)
63.49%
5-Year Return
ADAPY
99.65%
MSCI WORLD (^990100-USD-STRD)
46.14%
Earnings Trends
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
425.49%
-
Return on Assets (ttm)
-25.87%
-
Return on Equity (ttm)
-346.65%
-
Revenue (ttm)
5.92M
-
Net Income Avi to Common (ttm)
-78.01M
-
Diluted EPS (ttm)
-0.6700
Balance Sheet and Cash Flow
-
Total Cash (mrq)
25.95M
-
Total Debt/Equity (mrq)
44.05%
-
Levered Free Cash Flow (ttm)
-61.61M
